期刊文献+

急性脑梗死患者血清ADPN、S100-β蛋白、CRP/ALB变化及其对预后的预测价值 被引量:4

下载PDF
导出
摘要 目的 观察急性脑梗死患者血清脂联素(ADPN)、中枢神经特异性蛋白(S100-β)、C反应蛋白(CRP)/白蛋白(ALB)变化,并分析其与预后的关系。方法 选择急性脑梗死患者86例纳入病例组,轻度30例、中度35例、重度21例;选择86例健康体检者纳入对照组。检测两组血清ADPN、S100-β蛋白并计算CRP/ALB,分析病例组神经功能缺损严重程度与血清ADPN、S100-β蛋白及CRP/ALB的相关性。根据改良Rankin量表评分,将病例组分为预后良好亚组(0~2分)和预后较差亚组(3~5分),采用二元Logistic回归分析预后影响因素,采用受试者工作特征(ROC)曲线分析血清ADPN、S100-β蛋白及CRP/ALB对急性脑梗死预后的预测价值。结果 病例组血清ADPN低于对照组,S100-β蛋白、CRP/ALB高于对照组(P均<0.05);病例组轻、中、重度患者血清ADPN依次降低,S100-β蛋白、CRP/ALB依次升高(P均<0.05)。病例组神经功能缺损严重程度与血清ADPN呈负相关,与S100-β蛋白、CRP/ALB呈正相关(P均<0.05)。CRP/ALB、S100-β蛋白、ADPN是急性脑梗死预后独立影响因素。血清ADPNs、100β蛋白、CRP/ALB单项及三项联合预测急性脑梗死预后的ROC曲线下面积(AUC)分别为0.863、0.938、0.917、0.934;100β蛋白、CRP/ALB预测预后的AUC高于ADPN,三项指标联合预测的AUC高于ADPN、CRP/ALB单项指标预测(P均<0.05)。结论 急性脑梗死患者血清ADPN降低,S100-β蛋白、CRP/ALB升高,并与患者神经功能缺损程度有关;S100-β蛋白、CRP/ALB单项检测和血清ADPN、S100-β蛋白、CRP/ALB联合检测均有助于急性脑梗死患者的预后预测。
出处 《山东医药》 CAS 2023年第20期48-50,共3页 Shandong Medical Journal
  • 相关文献

参考文献16

二级参考文献159

  • 1黄渊炳,吴志林,李双涛,苏全喜,陈石伙,吴鉴洲,严银宗,黄金培,陈东燃.超时间窗急性前循环脑梗死患者血管内治疗的临床分析[J].广州医科大学学报,2019(4):50-54. 被引量:6
  • 2脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15717
  • 3Wijdicks EF, Sheth KN, Carter BS, et al. Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2014, 45(4): 1222-1238. DOI:10.1161/01 .str.0000441965.15164.d6.
  • 4lorbey MT, Bosel J, Rhoney DH, et al. Evidence-based guidelines for the management of large hemispheric infarction : a statement for health care professionals from the Neurocritical Care Society and the German Society for Neuro-intensive Care and Emergency Medicine[J]. Neurocrit Care, 2015, 22(1): 146-164. DOI: 10.1007/ s12028-014-0085-6.
  • 5Rabinstein AA, Wijdicks EF. Outcome of survivors of acute stroke who require prolonged ventilatory assistance and tracheostomy [J].Cerebrovasc Dis, 2004, 18(4): 325-331. DOI: 10.1016/S0040-8166 (02)00011-3.
  • 6Dennis M, Mordi N, Graham C, et al. The timing, extent, progression and regression of deep vein thrombosis in immobile stroke patients: observational data from the CLOTS muldcenter randomized trials[J]. J Thromb Haemost, 2011, 9(11): 2193-2200. DOI: 10.1111/j.1538-7836.2011.04486.x.
  • 7Berge E, Abdelnoor M, Nakstad PH, et al. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial [J]. Lancet, 2000, 355 (9211): 1205-1210. DOI: http://dx.DOI.org/10. 1016/S0140-6736(00)02085-7.
  • 8Graffagnino C, Gun'am AR, Kolls B, et al. Intensive insulin therapy in the neurocritical care setting is associated with poor clinical outcomes [J]. NeurocritCare, 2010, 13 (3): 307-312. DOI: 10.1007/s 12028-010-9469-4.
  • 9Vahedi K, Hofmeijer J, Juettler E, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials [J]. Lancet Neurol, 2007, 6 (3): 215-222. DOI: http://dx.DOI.org/10. 1016/S 1474- 4422(07)70036-4.
  • 10Smith SE, Kirkham FJ, Deveber G, et al. Outcome following decompressive craniectomy for malignant middle cerebral artery infarction in children [J]. Dev Med Child Neurol, 2011, 53 (1): 29-33. DOI: 10.1111/j.1469-8749.2010.03775.x.

共引文献306

同被引文献50

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部